Skip to Content

Scientific Whitewater

The Baltimore Case: A Trial of Politics, Science, and Character
November 1, 1998

Suspicions raised by biology postdoc Margot O’Toole about a few lines of data in a 1986 paper in the journal Cell by former MIT immunologist Thereza Imanishi-Kari, Nobel laureate David Baltimore and several co-workers snowballed into the late 20th century’s most public dispute over fraud and error in science. In 1991 The New York Times called it “A Scientific Watergate,” but a far more apt comparison is available today in the Whitewater investigation. Both the Baltimore saga and the Whitewater inquiry were pushed forward by obsessive, heavy-handed investigators with political agendas; both cases feature prominent targets who acted by turns indignant and contrite; and both matters dragged on interminably, with investigators chasing after details decreasingly related to the original alleged offenses. And just as the Whitewater inquiry long ago grew too convoluted for most citizens to grasp, the Baltimore case hinged on immunological experiments so arcane-and produced so many conflicting interpretations of the allegedly fabricated experimental records-that impartial observers rarely knew what to believe.

Daniel Kevles knows. An eminent historian of science at Caltech (where Baltimore was named president in 1997), Kevles not only examined Imanishi-Kari’s lab notebooks, which document the disputed experiments on the effect of gene transfers on antibody production in mice, but also waded through thousands of pages of testimony and interviewed more than 70 scientists and others caught up in the case, including all the principals. He concludes-as a Public Health Service appeals board did in 1996-that Imanishi-Kari is innocent of fakery. He also argues that Baltimore’s famously combative defense of Imanishi-Kari before muckraking Rep. John Dingell in 1989 congressional hearings was justified, if brash.

Kevles’ book is an opinionated and unsparing one. Kevles argues, for example, that O’Toole, criticized by Imanishi-Kari when she was unable to replicate parts of the gene transfer study, was guided largely by resentment and frustration over her own sputtering scientific career when she later charged that Imanishi-Kari had fudged the data from the original experiments. The scientifically sporting thing for O’Toole to do, he asserts, would have been to design new experiments to test competing hypotheses. “Baltimore…was right to contend that O’Toole’s critique of the Cell paper could be resolved not by argument but only by further research,” he observes. Kevles’ exhaustive critique of O’Toole’s charges and the way the government handled them, on the other hand, probably makes further research on what has gone down in history as “the Baltimore case” unnecessary.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.